From The Economic Times
Center-Right Owned by Bennett, Coleman & Co.Wockhardt seeks 14-year data shield for India-made drugs
RSS excerpt
Mumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for difficult-to-treat infections. In May this year, the company secured approvals from Indian and US drug regulators for a breakthrough drug, Zaynich (cefepime +…
